Abstract
Drug addiction is characterized by loss of control over drug consumption, with compulsive drug seeking and taking, despite obvious adverse consequences. It is a chronic brain disorder since the increased risk of relapse to active drug use remains high even after years of abstinence. Current research attempts to identify the cellular and molecular basis for the neuronal modifications underlying these complex behavioural alterations. Strong evidence indicates that the extracellular signal-regulated kinase (ERK) pathway is a conserved intracellular signalling module, critical for various types of learning and synaptic plasticity. Recent results show that drugs of abuse activate this pathway in the brain regions important for reward-controlled learning and addiction. Moreover, pharmacological and genetic approaches support a role of the ERK pathway in some of the long-term effects of addictive drugs. We suggest that drug-induced stimulation of the ERK pathway by dopamine in specific brain areas may be an exaggeration of its normal role in learning controlled by reward, and may contribute significantly to the acquisition of specific behaviours characteristic of drug addiction.
Keywords: extracellular signal-Regulated kinase, erk, reward-controlled learning, addiction, brain disorder, learning and synaptic plasticity, erk pathway, drug addiction
Current Neuropharmacology
Title: Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction
Volume: 1 Issue: 2
Author(s): Emmanuel Valjent, Denis Herve, Jocelyne Caboche and Jean-Antoine Girault
Affiliation:
Keywords: extracellular signal-Regulated kinase, erk, reward-controlled learning, addiction, brain disorder, learning and synaptic plasticity, erk pathway, drug addiction
Abstract: Drug addiction is characterized by loss of control over drug consumption, with compulsive drug seeking and taking, despite obvious adverse consequences. It is a chronic brain disorder since the increased risk of relapse to active drug use remains high even after years of abstinence. Current research attempts to identify the cellular and molecular basis for the neuronal modifications underlying these complex behavioural alterations. Strong evidence indicates that the extracellular signal-regulated kinase (ERK) pathway is a conserved intracellular signalling module, critical for various types of learning and synaptic plasticity. Recent results show that drugs of abuse activate this pathway in the brain regions important for reward-controlled learning and addiction. Moreover, pharmacological and genetic approaches support a role of the ERK pathway in some of the long-term effects of addictive drugs. We suggest that drug-induced stimulation of the ERK pathway by dopamine in specific brain areas may be an exaggeration of its normal role in learning controlled by reward, and may contribute significantly to the acquisition of specific behaviours characteristic of drug addiction.
Export Options
About this article
Cite this article as:
Valjent Emmanuel, Herve Denis, Caboche Jocelyne and Girault Jean-Antoine, Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction, Current Neuropharmacology 2003; 1 (2) . https://dx.doi.org/10.2174/1570159033477198
DOI https://dx.doi.org/10.2174/1570159033477198 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene Products
Current Gene Therapy Colloid Update
Current Pharmaceutical Design Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer’s Disease: Baseline Data from a DIAN Cohort Subset
Current Alzheimer Research Smoking and Congenital Heart Disease: The Epidemiological and Biological Link
Current Pharmaceutical Design PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
Endocrine, Metabolic & Immune Disorders - Drug Targets Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy The Heart and Brain Imaging in Lone Atrial Fibrillation – Are We Surprised?
Current Pharmaceutical Design Oxidative Stress, Sarcopenia, Antioxidant Strategies and Exercise: Molecular Aspects
Current Pharmaceutical Design The Involvement of Metallothioneins in Mitochondrial Function and Disease
Current Protein & Peptide Science The Role of Binding Kinetics in GPCR Drug Discovery
Current Topics in Medicinal Chemistry Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) NOD-Like Receptors: A Tail from Plants to Mammals Through Invertebrates
Current Protein & Peptide Science Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging The Role of STAT 3 in Tissue Fibrosis
Current Chemical Biology A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs
Current Cancer Therapy Reviews Prospects and Limitations of T Cell Receptor Gene Therapy
Current Gene Therapy Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews Immunomodulation of the Allergic Inflammatory Response: New Developments
Inflammation & Allergy - Drug Targets (Discontinued) A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome
CNS & Neurological Disorders - Drug Targets Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers